Revvity, Inc.
LSE: 0KHE.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Prahlad R. Singh
- Employees
- 11,000
- Headquarters
- Waltham, United States
- IPO year
- 2018
- Market cap
- $11.3B
- Website
- https://www.perkinelmer.com
Loading 0KHE…
Loading profile data…Frequently asked questions about 0KHE
What does Revvity, Inc. (0KHE.L) do?
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and i...
Where does 0KHE.L trade?
Revvity, Inc. (0KHE.L) trades on the London Stock Exchange.
What sector is 0KHE.L in?
Revvity, Inc. (0KHE.L) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Revvity, Inc.?
Prahlad R. Singh is the chief executive officer of Revvity, Inc. (0KHE.L).
Where is Revvity, Inc. headquartered?
Revvity, Inc. is headquartered in United States.
Does 0KHE.L pay a dividend?
Yes — Revvity, Inc. (0KHE.L) paid a trailing twelve-month dividend of USD 0.28 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 0KHE.L go public?
Revvity, Inc. (0KHE.L) completed its initial public offering in 2018.